A phase 2, double-blind, dose-finding, placebo-controlled study to assess the safety and efficacy of a single oral administration of OBE001 to improve embryo implantation following IVF or ICSI

Trial Profile

A phase 2, double-blind, dose-finding, placebo-controlled study to assess the safety and efficacy of a single oral administration of OBE001 to improve embryo implantation following IVF or ICSI

Completed
Phase of Trial: Phase II

Latest Information Update: 04 Oct 2017

At a glance

  • Drugs Nolasiban (Primary)
  • Indications Female infertility
  • Focus Therapeutic Use
  • Acronyms IMPLANT
  • Sponsors ObsEva
  • Most Recent Events

    • 29 Jun 2017 Results published in an ObsEva media release.
    • 29 Jun 2017 According to an ObsEva media release, results of post hoc analysis from this study will be presented in an oral presentation at the European Society of Human Reproduction and Embryology (ESHRE) 2017 Annual Meeting.
    • 07 Mar 2017 Results published in an ObsEva media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top